Literature DB >> 27614736

Donation After Circulatory Death Lungs Transplantable Up to Six Hours After Ex Vivo Lung Perfusion.

Eric J Charles1, Mary E Huerter1, Cynthia E Wagner1, Ashish K Sharma1, Yunge Zhao1, Mark H Stoler2, J Hunter Mehaffey1, James M Isbell1, Christine L Lau1, Curtis G Tribble1, Victor E Laubach1, Irving L Kron3.   

Abstract

BACKGROUND: Despite the critical need for donor lungs, logistic and geographic barriers hinder lung utilization. We hypothesized that lungs donated after circulatory death subjected to 6 hours of cold preservation after ex vivo lung perfusion (EVLP) would have similar outcomes after transplantation as lungs transplanted immediately after EVLP, and that both would perform superiorly compared with lungs transplanted immediately after procurement.
METHODS: Donor porcine lungs were procured after circulatory death and 15 minutes of warm ischemia. Three groups (n = 5 per group) were randomized: immediate left lung transplantation (Immediate group), EVLP for 4 hours followed by transplantation (EVLP group), or EVLP for 4 hours followed by 6 hours of cold preservation followed by transplantation (EVLP+Cold group). Lungs were reperfused for 2 hours before obtaining pulmonary vein samples for partial pressure of oxygen/fraction of inspired oxygen ratio calculations, airway pressures for compliance measurements, and wet/dry weight ratios.
RESULTS: The partial pressure of oxygen/fraction of inspired oxygen ratios in the EVLP and EVLP+Cold groups were significantly improved compared with those in the Immediate group (429.7 ± 51.8 and 436.7 ± 48.2 versus 117.4 ± 22.9 mm Hg, respectively). In addition, dynamic compliance was significantly improved in the EVLP and EVLP+Cold groups compared with immediate group (26.2 ± 4.2 and 27.9 ± 3.5 versus 11.1 ± 2.4 mL/cmH2O, respectively). There were no differences in oxygenation capacity or dynamic compliance between the EVLP and EVLP+Cold groups. Inflammatory cytokine levels were significantly lower in the EVLP and EVLP+Cold groups.
CONCLUSIONS: Lungs donated after circulatory death can be successfully transplanted as much as 6 hours after EVLP. Cold preservation of lungs after ex vivo assessment and rehabilitation may improve organ allocation, even to distant recipients, without compromising allograft function.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27614736      PMCID: PMC5112144          DOI: 10.1016/j.athoracsur.2016.06.043

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development.

Authors:  Yunge Zhao; Damien J LaPar; John Steidle; Abbas Emaminia; Irving L Kron; Gorav Ailawadi; Joel Linden; Christine L Lau
Journal:  J Heart Lung Transplant       Date:  2010-12       Impact factor: 10.247

2.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure.

Authors:  Roger D Yusen; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Samuel B Goldfarb; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Joseph W Rossano; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2015-09-03       Impact factor: 10.247

3.  Normothermic ex vivo lung perfusion in clinical lung transplantation.

Authors:  Marcelo Cypel; Jonathan C Yeung; Mingyao Liu; Masaki Anraku; Fengshi Chen; Wojtek Karolak; Masaaki Sato; Jane Laratta; Sassan Azad; Mindy Madonik; Chung-Wai Chow; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Arthur S Slutsky; Kazuhiro Yasufuku; Marc de Perrot; Andrew F Pierre; Thomas K Waddell; Shaf Keshavjee
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

Review 4.  Ex-vivo lung perfusion.

Authors:  Dirk Van Raemdonck; Arne Neyrinck; Marcelo Cypel; Shaf Keshavjee
Journal:  Transpl Int       Date:  2014-04-28       Impact factor: 3.782

5.  Adenosine A₂A agonist improves lung function during ex vivo lung perfusion.

Authors:  Abbas Emaminia; Damien J Lapar; Yunge Zhao; John F Steidle; David A Harris; Victor E Laubach; Joel Linden; Irving L Kron; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

6.  Hypothermia attenuates ischemia/reperfusion-induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK signaling.

Authors:  Dan Yang; Shubin Guo; Tianpeng Zhang; Huihua Li
Journal:  FEBS Lett       Date:  2009-07-16       Impact factor: 4.124

7.  Technique for prolonged normothermic ex vivo lung perfusion.

Authors:  Marcelo Cypel; Jonathan C Yeung; Shin Hirayama; Matthew Rubacha; Stefan Fischer; Masaki Anraku; Masaaki Sato; Stephen Harwood; Andrew Pierre; Thomas K Waddell; Marc de Perrot; Mingyao Liu; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2008-12       Impact factor: 10.247

8.  Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.

Authors:  Cynthia E Wagner; Nicolas H Pope; Eric J Charles; Mary E Huerter; Ashish K Sharma; Morgan D Salmon; Benjamin T Carter; Mark H Stoler; Christine L Lau; Victor E Laubach; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-30       Impact factor: 5.209

9.  International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report.

Authors:  Marcelo Cypel; Bronwyn Levvey; Dirk Van Raemdonck; Michiel Erasmus; John Dark; Robert Love; David Mason; Allan R Glanville; Daniel Chambers; Leah B Edwards; Josef Stehlik; Marshall Hertz; Brian A Whitson; Roger D Yusen; Varun Puri; Peter Hopkins; Greg Snell; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2015-09-03       Impact factor: 10.247

10.  Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.

Authors:  Daniel P Mulloy; Matthew L Stone; Ivan K Crosby; Damien J Lapar; Ashish K Sharma; David V Webb; Christine L Lau; Victor E Laubach; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-31       Impact factor: 5.209

View more
  14 in total

Review 1.  The Future of Lung Transplantation.

Authors:  Katherine A Young; Daniel F Dilling
Journal:  Chest       Date:  2018-08-29       Impact factor: 9.410

2.  In vivo lung perfusion rehabilitates sepsis-induced lung injury.

Authors:  J Hunter Mehaffey; Eric J Charles; Sarah Schubert; Morgan Salmon; Ashish K Sharma; Dustin Money; Mark H Stoler; Victor E Laubach; Curtis G Tribble; Mark E Roeser; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-14       Impact factor: 5.209

Review 3.  Ex vivo lung perfusion review of a revolutionary technology.

Authors:  George Makdisi; Tony Makdisi; Tambi Jarmi; Christiano C Caldeira
Journal:  Ann Transl Med       Date:  2017-09

4.  Ex Vivo Lung Perfusion Rehabilitates Sepsis-Induced Lung Injury.

Authors:  J Hunter Mehaffey; Eric J Charles; Ashish K Sharma; Morgan Salmon; Dustin Money; Sarah Schubert; Mark H Stoler; Curtis G Tribble; Victor E Laubach; Mark E Roeser; Irving L Kron
Journal:  Ann Thorac Surg       Date:  2017-04-21       Impact factor: 4.330

5.  Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion.

Authors:  J Hunter Mehaffey; Eric J Charles; Adishesh K Narahari; Sarah Schubert; Victor E Laubach; Nicholas R Teman; Kevin R Lynch; Irving L Kron; Ashish K Sharma
Journal:  J Thorac Cardiovasc Surg       Date:  2018-03-11       Impact factor: 5.209

Review 6.  Ex Vivo Lung Perfusion: Current Achievements and Future Directions.

Authors:  Nikhil K Prasad; Chetan Pasrija; Tara Talaie; Alexander S Krupnick; Yunge Zhao; Christine L Lau
Journal:  Transplantation       Date:  2021-05-01       Impact factor: 4.939

Review 7.  Molecular imaging of pulmonary diseases.

Authors:  Julien Dimastromatteo; Eric J Charles; Victor E Laubach
Journal:  Respir Res       Date:  2018-01-24

8.  Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death.

Authors:  Matthew L Stone; Yunge Zhao; J Robert Smith; Mark L Weiss; Irving L Kron; Victor E Laubach; Ashish K Sharma
Journal:  Respir Res       Date:  2017-12-21

9.  Ex Vivo Assessment of Porcine Donation After Circulatory Death Lungs That Undergo Increasing Warm Ischemia Times.

Authors:  Eric J Charles; J Hunter Mehaffey; Mary E Huerter; Ashish K Sharma; Mark H Stoler; Mark E Roeser; Dustin M Walters; Curtis G Tribble; Irving L Kron; Victor E Laubach
Journal:  Transplant Direct       Date:  2018-11-12

Review 10.  The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.

Authors:  Jasper Iske; Christopher A Hinze; Jawad Salman; Axel Haverich; Stefan G Tullius; Fabio Ius
Journal:  Am J Transplant       Date:  2021-08-24       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.